These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 22386755)
1. Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection. Urquidi V; Goodison S; Kim J; Chang M; Dai Y; Rosser CJ Urology; 2012 May; 79(5):1185.e1-6. PubMed ID: 22386755 [TBL] [Abstract][Full Text] [Related]
2. A multi-analyte assay for the non-invasive detection of bladder cancer. Goodison S; Chang M; Dai Y; Urquidi V; Rosser CJ PLoS One; 2012; 7(10):e47469. PubMed ID: 23094052 [TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer. de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037 [TBL] [Abstract][Full Text] [Related]
4. CCL18 in a multiplex urine-based assay for the detection of bladder cancer. Urquidi V; Kim J; Chang M; Dai Y; Rosser CJ; Goodison S PLoS One; 2012; 7(5):e37797. PubMed ID: 22629457 [TBL] [Abstract][Full Text] [Related]
5. Multiplex protein signature for the detection of bladder cancer in voided urine samples. Rosser CJ; Ross S; Chang M; Dai Y; Mengual L; Zhang G; Kim J; Urquidi V; Alcaraz A; Goodison S J Urol; 2013 Dec; 190(6):2257-62. PubMed ID: 23764080 [TBL] [Abstract][Full Text] [Related]
6. IL-8 as a urinary biomarker for the detection of bladder cancer. Urquidi V; Chang M; Dai Y; Kim J; Wolfson ED; Goodison S; Rosser CJ BMC Urol; 2012 May; 12():12. PubMed ID: 22559832 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic potential of urinary α1-antitrypsin and apolipoprotein E in the detection of bladder cancer. Urquidi V; Goodison S; Ross S; Chang M; Dai Y; Rosser CJ J Urol; 2012 Dec; 188(6):2377-83. PubMed ID: 23088986 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic evaluation of urinary angiogenin (ANG) and clusterin (CLU) as biomarker for bladder cancer. Shabayek MI; Sayed OM; Attaia HA; Awida HA; Abozeed H Pathol Oncol Res; 2014 Oct; 20(4):859-66. PubMed ID: 24696417 [TBL] [Abstract][Full Text] [Related]
9. Urinary BTA: indicator of bladder cancer or of hematuria. Miyake M; Goodison S; Rizwani W; Ross S; Bart Grossman H; Rosser CJ World J Urol; 2012 Dec; 30(6):869-73. PubMed ID: 22932760 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samples. Zhou BF; Wei JH; Chen ZH; Dong P; Lai YR; Fang Y; Jiang HM; Lu J; Zhou FJ; Xie D; Luo JH; Chen W Oncotarget; 2016 Jul; 7(27):41703-41714. PubMed ID: 27203388 [TBL] [Abstract][Full Text] [Related]
11. Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis. Aalami AH; Abdeahad H; Mesgari M; Sathyapalan T; Sahebkar A Biomed Res Int; 2021; 2021():5557309. PubMed ID: 33997007 [TBL] [Abstract][Full Text] [Related]
12. Urinary mRNA biomarker panel for the detection of urothelial carcinoma. Urquidi V; Netherton M; Gomes-Giacoia E; Serie D; Eckel-Passow J; Rosser CJ; Goodison S Oncotarget; 2016 Jun; 7(25):38731-38740. PubMed ID: 27231851 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the nuclear matrix protein 22 with voided urine cytology and BTA stat test in the diagnosis of transitional cell carcinoma of the bladder. Sözen S; Biri H; Sinik Z; Küpeli B; Alkibay T; Bozkirli I Eur Urol; 1999 Sep; 36(3):225-9. PubMed ID: 10450007 [TBL] [Abstract][Full Text] [Related]
14. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma. Bian W; Xu Z Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565 [TBL] [Abstract][Full Text] [Related]
15. Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer. Abd El Gawad IA; Moussa HS; Nasr MI; El Gemae EH; Masooud AM; Ibrahim IK; El Hifnawy NM J Egypt Natl Canc Inst; 2005 Sep; 17(3):193-202. PubMed ID: 16799657 [TBL] [Abstract][Full Text] [Related]
16. Urinary levels of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer. Nitta Y; Konishi H; Makino T; Tanaka T; Kawashima H; Iovanna JL; Nakatani T; Kiyama H BMC Urol; 2012 Sep; 12():24. PubMed ID: 22943287 [TBL] [Abstract][Full Text] [Related]
17. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria. Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818 [TBL] [Abstract][Full Text] [Related]
18. A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort. Goodison S; Ogawa O; Matsui Y; Kobayashi T; Miyake M; Ohnishi S; Fujimoto K; Dai Y; Shimizu Y; Tsukikawa K; Furuya H; Rosser CJ J Transl Med; 2016 Oct; 14(1):287. PubMed ID: 27717367 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic role of urinary collagens in primary human bladder cancer. Miyake M; Morizawa Y; Hori S; Tatsumi Y; Onishi S; Owari T; Iida K; Onishi K; Gotoh D; Nakai Y; Anai S; Chihara Y; Torimoto K; Aoki K; Tanaka N; Shimada K; Konishi N; Fujimoto K Cancer Sci; 2017 Nov; 108(11):2221-2228. PubMed ID: 28837258 [TBL] [Abstract][Full Text] [Related]
20. Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker. Choi S; Shin JH; Lee YR; Joo HK; Song KH; Na YG; Chang SJ; Lim JS; Jeon BH Dis Markers; 2016; 2016():7276502. PubMed ID: 27057081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]